NASDAQ · Drug Manufacturers - Specialty & Generic
Tilray Inc (TLRY)
$1.89
-8.70%
27
Oversold
Moving averages
SMA 200$5.22-63.79%
Company profile
Tilray Inc. is dedicated to the research, cultivation, production and distribution of medicinal cannabis and cannabinoids. The company is headquartered in Leamington, Canada.
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Market cap$367.99M
P/E ratioNone
EPS$-1.41
Beta2.055
Dividend yield0.00%
52-week high$15.70
52-week low$2.47
Similar stocks in Drug Manufacturers - Specialty & Generic
HIMS
Hims & Hers Health Inc - Class A
RSI 27
CGC
Canopy Growth Corporation
RSI 21
BFRI
Biofrontera Inc
RSI 31
LNTH
Lantheus Holdings Inc
RSI 68
ACB
Aurora Cannabis Inc
RSI 45
ORGO
Organogenesis Holdings Inc - Class A
RSI 38
BCRX
Biocryst Pharmaceuticals Inc
RSI 37
INM
InMed Pharmaceuticals Inc
RSI 54
RSI alerts for TLRY
An email when TLRY closes below RSI 30 or above 70. Nothing else.
Data last updated 13 November 2026 at 5:47 AM EST